SMART had the honour of participating in the 9th Princess Chulabhorn International Science Congress, held from 15 to 18 December 2024 at the Shangri-La Hotel in Bangkok, Thailand. Organised by the Chulabhorn Research Institute (CRI) and opened by the World Health Organisation (WHO) Director-General Tedros Adhanom Ghebreyesus, the congress focused on the theme, “The Challenges of One Health: The Roles of Biosciences and Chemistry,” emphasising the environmental sources, treatment, and prevention of cancer, infectious disease, and antimicrobial resistance as global challenges.
SMART’s Antimicrobial Resistance (AMR) team actively participated with invited presentations and high-level discussions with representatives from leading international regulatory agencies and research institutions such as the US Food and Drug Administration (FDA), Thai FDA, US National Institutes of Health, Tufts University, Nanyang Technological University, National University of Singapore, and Massachusetts Institute of Technology.
At the congress, Prof Peter Dedon, Co-Lead Principal Investigator spoke on AMR drug discovery while Prof Ram Sasisekharan, Principal Investigator presented a keynote lecture and chaired a panel discussion on drug regulatory sciences. AMR IRG was also represented by poster presenters Dr Wei Lin Lee, Principal Research Scientist, Dr Peiying Ho, Senior Research Manager and Dr Megan McBee, Senior Scientific Director, as well as Prof Peter Preiser, Co-Lead Principal Investigator, Dr Farzad Olfat, Senior Director for Research Facilities and Tsie Mien Tan, Senior Laboratory Manager.
SMART AMR researchers at the 9th Princess Chulabhorn International Science Congress
Left to right: back - Prof Peter Preiser and Prof Peter Dedon; front - Dr Wei Lin Lee, Tse Mien Tan, Dr Peiying Ho, Dr Megan McBee and Dr Farzad Olfat.
The AMR team shared insights into current advancements in antimicrobial drug discovery, drug target identification, and the analysis of wastewater and AMR genes in human guts. Additionally, they discussed innovative approaches to improve access to therapies. Throughout the congress, SMART AMR researchers also engaged in thought-provoking discussions and had the opportunity to network and exchange information with leading researchers and experts from various research disciplines.
Left: Prof Peter Dedon, Co-Lead Principal Investigator at SMART AMR and Right: Prof Peter Preiser, Co-Lead Principal Investigator at SMART AMR actively engaged in discussion with speakers of the Congress.
Following the congress, SMART AMR emerged with renewed enthusiasm and several actionable tasks focused on strengthening collaborations within Singapore and the broader region. The discussions not only broadened their scientific perspectives but also reinforced their commitment to integrating biosciences and chemistry into global health solutions.
留言